Barriers to Recognition and Treatment of Myalgic Encephalomyelitis (M.E.)

Purpose

This page explains why many people with Myalgic Encephalomyelitis (M.E.) struggle to receive proper diagnosis, recognition, and medical care. It outlines the historical, systemic, and cultural factors that have contributed to the dismissal and under-treatment of the condition.

Key Points

1. Historical Misclassification

• Early outbreaks of M.E. were documented as a neurological illness
• Later reclassification as “Chronic Fatigue Syndrome (CFS)” shifted focus to fatigue
• This removed recognition of the neurological and systemic nature of the disease
• The change led to long-term confusion in diagnosis and treatment

2. Gaps in Medical Training

• M.E. is rarely taught in medical education
• Often presented as vague or “unexplained fatigue”
• Doctors graduate without knowledge of:
  • Neurological dysfunction
  • Immune abnormalities
  • Circulatory and metabolic issues

3. Influence of Psychiatric Models

• Some medical frameworks classify M.E. as psychological or behavioural
• Treatments such as:
  • Cognitive Behavioural Therapy (CBT)
  • Graded Exercise Therapy (GET)
    have been promoted despite controversy and reported harm
• This has contributed to dismissal of patients as having psychosomatic illness

4. Policy and System Pressures

• Recognising M.E. as a serious physical illness may increase:
  • Healthcare costs
  • Disability support demands
• Classifying it as fatigue-related allows:
  • Simplified management
  • Reduced financial burden on systems
• These pressures can influence clinical attitudes

5. Diagnostic Challenges

• No single definitive test for M.E.
• Diagnosis relies on clinical assessment
• Many clinicians are uncomfortable diagnosing complex, multi-system illnesses
• This can lead to avoidance or misclassification

6. Complexity of the Disease

• M.E. affects multiple systems, including:
  • Neurological
  • Immune
  • Cardiovascular
  • Metabolic
• This complexity can:
  • Overwhelm clinicians
  • Lead to reluctance to treat
  • Result in fragmented care

7. Stigma and Patient Blame

• Patients may be labelled as:
  • “Difficult”
  • “Non-compliant”
  • “Exaggerating symptoms”
• Normal routine tests can reinforce disbelief
• Patients who question inappropriate treatments may be dismissed

8. Gender Bias

• M.E. disproportionately affects women
• Historical patterns show women’s illnesses are more likely to be dismissed
• Symptoms may be incorrectly attributed to emotional or psychological causes

9. Limited Awareness of Biomedical Research

• Research has identified:
  • Neuroinflammation
  • Circulatory abnormalities
  • Immune dysfunction
• However:
  • Limited funding and awareness
  • Dominance of older models
• Means many clinicians are unaware of these findings

10. Historical Parallels with Other Diseases

Similar patterns of dismissal have occurred in other conditions, including:

• Multiple Sclerosis
• Lupus
• Fibromyalgia
• Asthma
• Peptic ulcers
• Endometriosis

Common pattern:

1. Symptoms not fully understood
2. Condition labelled psychological
3. Patients dismissed
4. Biomedical evidence later confirms physical cause
5. Recognition comes after years of neglect

Target Audience

This information is intended for:

• People living with M.E.
• Carers and family members
• Healthcare professionals
• Researchers and advocates

Overall Outcome

This page highlights that the lack of recognition and treatment of M.E. is not due to the absence of illness, but rather a combination of historical misclassification, systemic limitations, and ongoing gaps in medical understanding.

Understanding these barriers helps:

• Validate patient experiences
• Improve awareness among clinicians
• Support better diagnosis and care
• Encourage more accurate research and policy development

Key Summary Statement

The lack of recognition and treatment of M.E. stems from historical misclassification, gaps in medical education, systemic pressures, and stigma—rather than the absence of a real and complex biological disease.